Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    24091311 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Safety and Immunogenicity of GlaxoSmithKline Biologicals' HPV Vaccine 580299 (Cervarix TM) in HIV Infected Females
Conditions: HPV-16/18 Infections;   Cervical Neoplasia
Interventions: Biological: Cervarix TM;   Biological: Placebo Control

Indicates status has not been verified in more than two years